NGS-based RNA-seq Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4131244
- 96 Pages
- December 2020
- Healthcare
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global NGS-based RNA-seq market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global NGS-based RNA-seq market segmented into
Sample Preparation
Sample Preparation, by Method
Sequencing Platforms & Consumables for RNA-Seq
RNA Sequencing Services
Data Analysis, Storage, and Management
Based on the end-use, the global NGS-based RNA-seq market classified into
De Novo Transcriptome Assembly
Expression Profiling Analysis
Variant Calling and Transcriptome Epigenetics
Small RNA Sequencing
Based on geography, the global NGS-based RNA-seq market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Illumina
Thermo Fisher Scientific
Pacific Biosciences of California
QIAGEN
BGI
Oxford Nanopore Technologies
PerkinElmer
GATC Biotech
Agilent Technologies
Roche
Macrogen
Eurofins Scientific
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL NGS-BASED RNA-SEQ INDUSTRY
2.1 Summary about NGS-based RNA-seq Industry
2.2 NGS-based RNA-seq Market Trends
2.2.1 NGS-based RNA-seq Production & Consumption Trends
2.2.2 NGS-based RNA-seq Demand Structure Trends
2.3 NGS-based RNA-seq Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Sample Preparation
4.2.2 Sample Preparation, by Method
4.2.3 Sequencing Platforms & Consumables for RNA-Seq
4.2.4 RNA Sequencing Services
4.2.5 Data Analysis, Storage, and Management
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 De Novo Transcriptome Assembly
4.3.2 Expression Profiling Analysis
4.3.3 Variant Calling and Transcriptome Epigenetics
4.3.4 Small RNA Sequencing
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Sample Preparation
5.2.2 Sample Preparation, by Method
5.2.3 Sequencing Platforms & Consumables for RNA-Seq
5.2.4 RNA Sequencing Services
5.2.5 Data Analysis, Storage, and Management
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 De Novo Transcriptome Assembly
5.3.2 Expression Profiling Analysis
5.3.3 Variant Calling and Transcriptome Epigenetics
5.3.4 Small RNA Sequencing
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Sample Preparation
6.2.2 Sample Preparation, by Method
6.2.3 Sequencing Platforms & Consumables for RNA-Seq
6.2.4 RNA Sequencing Services
6.2.5 Data Analysis, Storage, and Management
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 De Novo Transcriptome Assembly
6.3.2 Expression Profiling Analysis
6.3.3 Variant Calling and Transcriptome Epigenetics
6.3.4 Small RNA Sequencing
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Sample Preparation
7.2.2 Sample Preparation, by Method
7.2.3 Sequencing Platforms & Consumables for RNA-Seq
7.2.4 RNA Sequencing Services
7.2.5 Data Analysis, Storage, and Management
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 De Novo Transcriptome Assembly
7.3.2 Expression Profiling Analysis
7.3.3 Variant Calling and Transcriptome Epigenetics
7.3.4 Small RNA Sequencing
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Sample Preparation
8.2.2 Sample Preparation, by Method
8.2.3 Sequencing Platforms & Consumables for RNA-Seq
8.2.4 RNA Sequencing Services
8.2.5 Data Analysis, Storage, and Management
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 De Novo Transcriptome Assembly
8.3.2 Expression Profiling Analysis
8.3.3 Variant Calling and Transcriptome Epigenetics
8.3.4 Small RNA Sequencing
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Sample Preparation
9.2.2 Sample Preparation, by Method
9.2.3 Sequencing Platforms & Consumables for RNA-Seq
9.2.4 RNA Sequencing Services
9.2.5 Data Analysis, Storage, and Management
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 De Novo Transcriptome Assembly
9.3.2 Expression Profiling Analysis
9.3.3 Variant Calling and Transcriptome Epigenetics
9.3.4 Small RNA Sequencing
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Illumina
10.1.2 Thermo Fisher Scientific
10.1.3 Pacific Biosciences of California
10.1.4 QIAGEN
10.1.5 BGI
10.1.6 Oxford Nanopore Technologies
10.1.7 PerkinElmer
10.1.8 GATC Biotech
10.1.9 Agilent Technologies
10.1.10 Roche
10.1.11 Macrogen
10.1.12 Eurofins Scientific
10.2 NGS-based RNA-seq Sales Date of Major Players (2017-2020e)
10.2.1 Illumina
10.2.2 Thermo Fisher Scientific
10.2.3 Pacific Biosciences of California
10.2.4 QIAGEN
10.2.5 BGI
10.2.6 Oxford Nanopore Technologies
10.2.7 PerkinElmer
10.2.8 GATC Biotech
10.2.9 Agilent Technologies
10.2.10 Roche
10.2.11 Macrogen
10.2.12 Eurofins Scientific
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
Table NGS-based RNA-seq Product Type Overview
Table NGS-based RNA-seq Product Type Market Share List
Table NGS-based RNA-seq Product Type of Major Players
Table Brief Introduction of Illumina
Table Brief Introduction of Thermo Fisher Scientific
Table Brief Introduction of Pacific Biosciences of California
Table Brief Introduction of QIAGEN
Table Brief Introduction of BGI
Table Brief Introduction of Oxford Nanopore Technologies
Table Brief Introduction of PerkinElmer
Table Brief Introduction of GATC Biotech
Table Brief Introduction of Agilent Technologies
Table Brief Introduction of Roche
Table Brief Introduction of Macrogen
Table Brief Introduction of Eurofins Scientific
Table Products & Services of Illumina
Table Products & Services of Thermo Fisher Scientific
Table Products & Services of Pacific Biosciences of California
Table Products & Services of QIAGEN
Table Products & Services of BGI
Table Products & Services of Oxford Nanopore Technologies
Table Products & Services of PerkinElmer
Table Products & Services of GATC Biotech
Table Products & Services of Agilent Technologies
Table Products & Services of Roche
Table Products & Services of Macrogen
Table Products & Services of Eurofins Scientific
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global NGS-based RNA-seq Market Forecast (Million USD) by Region 2021f-2026f
Table Global NGS-based RNA-seq Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global NGS-based RNA-seq Market Forecast (Million USD) by Demand 2021f-2026f
Table Global NGS-based RNA-seq Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
